These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12640959)
81. Nesiritide vs nitroglycerin for decompensated congestive heart failure. Dunavant S JAMA; 2002 Aug; 288(5):571-2; author reply 572-3. PubMed ID: 12150661 [No Abstract] [Full Text] [Related]
82. Nesiritide vs nitroglycerin for decompensated congestive heart failure. Rifkin W JAMA; 2002 Aug; 288(5):572; author reply 572-3. PubMed ID: 12150662 [No Abstract] [Full Text] [Related]
83. The tumultuous journey of nesiritide: past, present, and future. Burnett JC; Korinek J Circ Heart Fail; 2008 May; 1(1):6-8. PubMed ID: 19808264 [No Abstract] [Full Text] [Related]
84. Nesiritide in perspective: evolving approaches to the management of acute decompensated heart failure. Mills RM; Hobbs RE Drugs Today (Barc); 2003 Oct; 39(10):767-74. PubMed ID: 14668932 [TBL] [Abstract][Full Text] [Related]
85. Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure. O'Dell KM; Kalus JS; Kucukarslan S; Czerska B Am J Health Syst Pharm; 2005 Mar; 62(6):606-9. PubMed ID: 15757881 [TBL] [Abstract][Full Text] [Related]
86. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF). Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ; Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453 [No Abstract] [Full Text] [Related]
87. How to use nesiritide in treating decompensated heart failure. Mills RM; Hobbs RE Cleve Clin J Med; 2002 Mar; 69(3):252-6. PubMed ID: 11890216 [TBL] [Abstract][Full Text] [Related]
88. The role of intravenous vasodilators in acute heart failure management. Piper S; McDonagh T Eur J Heart Fail; 2014 Aug; 16(8):827-34. PubMed ID: 25100108 [TBL] [Abstract][Full Text] [Related]
89. Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure. de Lissovoy G; Stier DM; Ciesla G; Munger M; Burger AJ Am J Cardiol; 2003 Sep; 92(5):631-3. PubMed ID: 12943895 [TBL] [Abstract][Full Text] [Related]
90. Does nesiritide offer something new in the management of pediatric heart failure? Baden HP Pediatr Crit Care Med; 2005 Sep; 6(5):613-4. PubMed ID: 16148832 [No Abstract] [Full Text] [Related]
91. B-type natriuretic peptide for the treatment of congestive heart failure. Schreiner GF; Protter AA Curr Opin Pharmacol; 2002 Apr; 2(2):142-7. PubMed ID: 11950624 [TBL] [Abstract][Full Text] [Related]
93. The role of brain natriuretic peptide in systolic heart failure. White RM Dimens Crit Care Nurs; 2005; 24(4):171-4. PubMed ID: 16043978 [TBL] [Abstract][Full Text] [Related]
98. The use of nesiritide in the management of acute decompensated heart failure. 2002. Kayser SR Prog Cardiovasc Nurs; 2007; 22(4):89-95. PubMed ID: 18172951 [No Abstract] [Full Text] [Related]